Sorry, you need to enable JavaScript to visit this website.

Pharmaceuticals

Alternative labels
Medication
Pharmaceutical industry
Subject Hierarchy
Permalinks
APO URI

ADVERTISEMENT

Journal article

The crux of the matter: did the ABC's Catalyst program change statin use in Australia?

This article argues that the ABC’s Catalyst program criticising statins affected people’s willingness to take these drugs. Abstract Objectives: To examine the impact of a two-part special edition of the Australian Broadcasting Corporation's science journalism program Catalyst (titled Heart of the m atter), aired in October 2013, that was critical of HMG-CoA reductase inhibitors (“statins”)...
Fact sheet

Fact Check: How much is subsidising cheap paracetamol costing the government?


Health Minister Sussan Ley claims subsidising paracetamol that can be bought cheaply without a prescription is costing the government $73 million a year.
Report

How do drug prices respond to a change from external to internal reference pricing? Evidence from a Danish regulatory reform


Studies the effects of a switch from external reference pricing to internal reference pricing that was implemented in Denmark in April 2005. Abstract We study the effects of a change in the way patient reimbursements are calculated on the prices of pharmaceuticals using quasi-experimental data for Denmark which switched from external (where reimbursements are based...
Report

Avoiding, acknowledging and fixing mistakes: investigation of a complaint about the Australian Community Pharmacy Authority


This investigation into the approval process for pharmaceuticals produced findings with broader lessons for Commonwealth agencies about the importance of proper program design, sharing information necessary to ensure proper outcomes and about service recovery arrangements when things go wrong.
Audio

PrEP pill: 'party drug' or life saver?


With HIV infections in Australia at a 20-year high, there’s a push to subsidise a daily pill that can stop transmission, but health professionals and the gay community are split over the drug, which some say will encourage risky sexual behaviour and could place a huge burden on the public health purse. Hagar Cohen investigates...